4.7 Article

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

Journal

NATURE IMMUNOLOGY
Volume 12, Issue 6, Pages 560-U248

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2027

Keywords

-

Categories

Funding

  1. Swiss National Science Foundation [31003AB.131091]
  2. Swiss Multiple Sclerosis Society
  3. Koetser Foundation
  4. Merck-Serono-Geneva
  5. Forschungskredit of the University of Zurich
  6. Gemeinnutzige Hertie-Stiftung
  7. Swiss National Science Foundation (SNF) [31003AB_131091] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Although the role of the T(H)1 and T(H)17 subsets of helper T cells as disease mediators in autoimmune neuroinflammation remains a subject of some debate, none of their signature cytokines are essential for disease development. Here we report that interleukin 23 (IL-23) and the transcription factor ROR gamma t drove expression of the cytokine GM-CSF in helper T cells, whereas IL-12, interferon-gamma (IFN-gamma) and IL-27 acted as negative regulators. Autoreactive helper T cells specifically lacking GM-CSF failed to initiate neuroinflammation despite expression of IL-17A or IFN-gamma, whereas GM-CSF secretion by Ifng(-/-)Il17a(-/-)helper T cells was sufficient to induce experimental autoimmune encephalomyelitis (EAE). During the disease effector phase, GM-CSF sustained neuroinflammation via myeloid cells that infiltrated the central nervous system. Thus, in contrast to all other known helper T cell-derived cytokines, GM-CSF serves a nonredundant function in the initiation of autoimmune inflammation regardless of helper T cell polarization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available